期刊文献+

P53与肺癌病理、CT征象及预后的关系 被引量:10

Study on the Relationship between P53 Gene and Pathology,CT Imaging and Prognosis of Lung Cancer
下载PDF
导出
摘要 目的 探讨 P5 3基因突变与肺癌的临床病理、CT征象、TNM分期及预后的关系。方法 收集 146例肺癌患者的标本 ,分别行 HE染色观察基本病理情况和 SP法免疫组化染色检测 P5 3表达结果。结果  146例周围型肺癌中 ,有深分叶、细毛刺、棘状突起、肿瘤强化增 CT值 >2 0 Hu者 ,其 P5 3基因表达率明显高于无深分叶、细毛刺、棘状突起、肿瘤强化增 CT值 <2 0 Hu(P<0 .0 1)。肿瘤大小、空洞、空泡征、空气支气管征、胸膜凹陷征与 P5 3表达无关 (P>0 .0 5 )。P5 3蛋白免疫组化阳性 75例 (5 1.36 % ) ,5 a生存率分析 ,P5 3基因表达组明显低于无 P5 3异常表达组。结论  P5 3基因突变可作为判断周围型肺癌恶性程度及预后的重要指标之一。 CT表现有深分叶、细毛刺、棘状突起、肿瘤强化增 CT值 >2 0 Hu者可能与 P5 3基因异常表达有关 。 Objective To investigate the relationship between P53 gene mutations and pathology,CT imaging,and prognosis of lung cancer.Methods 146 cases of lung carcinoma were reviewed retrospectively.HE staining and immunohistochemical SP method were performed to observe the general pathological changes and the expression of P53 respectively.Results The expression of P53 in lung carcinoma with deep lobulation,thin specula,thorn spicule,Enhanced density >20Hu was significantly higher compared with the carcinoma without the above mentioned characteristics.(P<0.01).The size,cavity,vacuole sign, air bronchogram, pleural indentation sign of the tumor showed no relationship with the expression of P53 gene (P>0.05).There were 75 cases (51.36%)of P53 protein positive.5 year survival rate of patients with P53 gene mutation was significantly lower than that of patients with nomal P53 expression.Conclusion The mutation of P53 could be one of valuble tools for estimating the severity and prognosis of lung carcinoma.The characteristics of CT imaging mentioned above might be related to P53 mutation,and also suggested a bad prognosis.
出处 《中国误诊学杂志》 CAS 2002年第2期164-167,共4页 Chinese Journal of Misdiagnostics
基金 湖北省科技厅"十五"攻关计划资助 编号2 0 0 0 1 P1 80 4
关键词 P53基因 肺肿瘤 病理学 X线计算机体层术 预后 Genes,P53 Lung neoplasms/pathology Tomography,X ray computed Prognosis
  • 相关文献

参考文献15

  • 1Christina R Mcpake,Sheetal shetty,Geoffrey R Kitchingman,et al.Wild-Type p53 induction mediated by replication-deficient adenoviral vectors.Cancer research,1999,59(9):4247-4251
  • 2杨树勤.卫生统计学(第3版)[M].北京:人民卫生出版社,1996.61-62.
  • 3卢晓晔,黄中新,夏潮涌.以阳性水平指数作为肺癌p53表达水平指标的探讨[J].临床与实验病理学杂志,1997,13(2):101-103. 被引量:5
  • 4Alexander devries,jurgen Griebel,Christian Kremser,et al.Monitoring of tumor microcirrculation during fractiomated radiatiom therapy in patients with rectal carcinoma:preliminary results and implications for therapy.Radiology,2000,217(2):385-391
  • 5Johnson BE,Eclley MJ.Overview of genetic and molecular event in pathogenesis of lung cancer.Chest,1993,103(1):1-3
  • 6Chang F,Syrjanen S,Syrjanen K.Implications of the p53 tumor-suppresor gene in clinical oncology.J Clin Oncol,1995,14(10):5638-5644
  • 7Ko LD,Prives C.P53:puzzle and paradigm.Genes Development,1996,10(3):1054-1062
  • 8Velculescu VE,SL-Deriry Ws.Biological and clinical importance of the p53tumor suppressor gene.Clin chem,1996,42(2):858-864
  • 9李松年,方继良.基因治疗与放射学[J].中华放射学杂志,2000,34(10):655-658. 被引量:7
  • 10Gianfranco Buccheri,Domenico Ferrigno.Prognostic Value of stage grouping and TNM descriptors in lung cancer.Chest,2000,117(5):1247-1255

二级参考文献9

共引文献58

同被引文献104

引证文献10

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部